HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Oskar Haas Selected Research
Oskar Haas Research Topics
Disease
2
Neoplasms (Cancer)
08/2022 - 01/2018
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
08/2022 - 01/2010
2
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2014 - 03/2003
1
Hepatocellular Carcinoma (Hepatoma)
02/2018
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
01/2018
1
Pdgfra-Associated Chronic Eosinophilic Leukemia
04/2014
1
Leukemia
01/2010
1
Neuroendocrine Tumors (Neuroendocrine Tumor)
06/2009
1
Rett Syndrome (Rett's Disorder)
05/2007
1
Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
04/2006
1
Lymphoma (Lymphomas)
04/2006
Drug/Important Bio-Agent (IBA)
1
Mutagens
IBA
02/2018
1
Imatinib Mesylate (Gleevec)
FDA Link
04/2014
1
Oncogene Proteins (Oncogene Protein)
IBA
04/2014
1
Peroxidase (Myeloperoxidase)
IBA
01/2010
1
glycocyamine
IBA
05/2007
1
Creatine
IBA
05/2007
1
Creatinine
IBA
05/2007
1
Homocysteine
IBA
05/2007
1
Methionine (L-Methionine)
FDA Link
05/2007
1
Anaplastic Lymphoma Kinase
IBA
04/2006
1
Interleukin-7 (Interleukin 7)
IBA
03/2003
1
Neoplasm Antigens (Tumor Antigens)
IBA
03/2003
1
Antigens
IBA
03/2003
Therapy/Procedure
3
Therapeutics
01/2018 - 06/2009
1
Aftercare (After-Treatment)
08/2022
1
ICE protocol 4
01/2014